|
US4559157A
(en)
|
1983-04-21 |
1985-12-17 |
Creative Products Resource Associates, Ltd. |
Cosmetic applicator useful for skin moisturizing
|
|
LU84979A1
(fr)
|
1983-08-30 |
1985-04-24 |
Oreal |
Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
|
|
DE3441788A1
(de)
|
1984-11-15 |
1986-05-15 |
Bayer Ag, 5090 Leverkusen |
Alkyl-1-cyclopropyl-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
|
|
US4820508A
(en)
|
1987-06-23 |
1989-04-11 |
Neutrogena Corporation |
Skin protective composition
|
|
US4992478A
(en)
|
1988-04-04 |
1991-02-12 |
Warner-Lambert Company |
Antiinflammatory skin moisturizing composition and method of preparing same
|
|
US4938949A
(en)
|
1988-09-12 |
1990-07-03 |
University Of New York |
Treatment of damaged bone marrow and dosage units therefor
|
|
US5962731A
(en)
|
1992-04-22 |
1999-10-05 |
Ligand Pharmaceuticals Incorporated |
Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
|
|
US7655699B1
(en)
|
1992-04-22 |
2010-02-02 |
Eisai Inc. |
Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
|
|
US5780676A
(en)
|
1992-04-22 |
1998-07-14 |
Ligand Pharmaceuticals Incorporated |
Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
|
|
DE69333894D1
(de)
|
1992-04-22 |
2005-12-01 |
Ligand Pharm Inc |
Verbindungen mit Retinoid x rezeptorselektivität
|
|
US6137002A
(en)
|
1993-07-22 |
2000-10-24 |
Eli Lilly And Company |
Glycoprotein IIb/IIIa antagonists
|
|
AU726450B2
(en)
*
|
1995-10-06 |
2000-11-09 |
Ligand Pharmaceuticals Incorporated |
Dimer-selective RXR modulators and methods for their use
|
|
FR2746101B1
(fr)
|
1996-03-14 |
1998-04-30 |
|
Composes bicycliques-aromatiques
|
|
AU6895198A
(en)
*
|
1997-04-11 |
1998-11-11 |
Sidney Kimmel Cancer Center |
Retinoid related molecules for the inhibition of endothelin-1 overproduction in disease
|
|
FR2776657B1
(fr)
*
|
1998-03-31 |
2000-05-26 |
Cird Galderma |
Composes bicycliques-aromatiques et leur utilisation en medecine humaine ou veterinaire ainsi qu'en cosmetologie
|
|
IL138772A0
(en)
*
|
1998-05-06 |
2001-10-31 |
Galderma Res & Dev |
Assay for identification of compounds that promote melanin production and retinoid-like compounds identified by said assay
|
|
WO2000066595A1
(en)
|
1999-04-28 |
2000-11-09 |
Institute Of Medicinal Molecular Design. Inc. |
Heterocyclic carboxylic acid derivatives
|
|
US6303785B1
(en)
|
2000-08-29 |
2001-10-16 |
Allergan Sales, Inc. |
Compounds having activity as inhibitors of cytochrome P450RAI
|
|
CA2420869A1
(en)
|
2000-08-29 |
2002-03-07 |
Allergan, Inc. |
Compounds having activity as inhibitors of cytochrome p450rai
|
|
US6291677B1
(en)
|
2000-08-29 |
2001-09-18 |
Allergan Sales, Inc. |
Compounds having activity as inhibitors of cytochrome P450RAI
|
|
US6313107B1
(en)
|
2000-08-29 |
2001-11-06 |
Allergan Sales, Inc. |
Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
|
|
BR0317430A
(pt)
|
2002-12-20 |
2005-10-25 |
Pharmacia Corp |
Compostos inibidores de quinase-2 de proteìna ativada por quinase de proteìna ativada por mitógeno
|
|
AU2004263156B2
(en)
*
|
2003-08-07 |
2009-02-26 |
Allergan, Inc. |
Method for treating cachexia with retinoid ligands
|
|
EP1541549A1
(en)
|
2003-12-12 |
2005-06-15 |
Exonhit Therapeutics S.A. |
Tricyclic hydroxamate and benzaminde derivatives, compositions and methods
|
|
US7226951B2
(en)
|
2003-12-17 |
2007-06-05 |
Allergan, Inc. |
Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same
|
|
JP2007515433A
(ja)
|
2003-12-17 |
2007-06-14 |
アラーガン インコーポレイテッド |
Ｃｙｐ２６ａおよびｃｙｐ２６ｂの選択的阻害剤を使用するレチノイド反応性障害の処置方法
|
|
US20080234229A1
(en)
|
2005-08-18 |
2008-09-25 |
Auspex Pharmaceuticals, Inc. |
Novel Therapeutic Agents for the Treatment of Cancer, Metabolic Diseases and Skin Disorders
|
|
JP2010503615A
(ja)
*
|
2006-08-29 |
2010-02-04 |
レインナーベート リミテッド |
レチノイド化合物およびそれらの使用
|
|
CN107652212B
(zh)
|
2007-01-15 |
2019-11-15 |
于崇曦 |
维生素a酸类和类维生素a酸化合物的前药
|
|
WO2010096264A2
(en)
|
2009-02-03 |
2010-08-26 |
Children's Medical Center Corporation |
Methods for enhancing hematopoietic stem/progenitor cell engraftment
|
|
WO2011006157A2
(en)
|
2009-07-10 |
2011-01-13 |
Case Western Reserve University |
Rxr agonist compounds and methods
|
|
US9096544B2
(en)
*
|
2009-12-23 |
2015-08-04 |
Wayne State University |
Therapeutic compounds
|
|
CA2790318A1
(en)
|
2010-02-19 |
2011-08-25 |
Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acti Ng For And On Behalf Of Arizona State University |
Novel bexarotene analogs
|
|
JP5743129B2
(ja)
|
2010-04-16 |
2015-07-01 |
Dic株式会社 |
重合性化合物を含有する液晶組成物及びそれを使用した液晶表示素子
|
|
JP2014527083A
(ja)
|
2011-09-15 |
2014-10-09 |
アリゾナ ボード オブ リージェンツ， ア ボディー コーポレイト オブ ザ ステート オブ アリゾナ， アクティング フォー アンド オン ビハーフ オブ アリゾナ ステート ユニバーシティー |
治療用化合物
|